Sequential treatment of icotinib after first-line pemetrexed in advanced lung adenocarcinoma with unknown EGFR gene status

BACKGROUND: In non-small cell lung cancer (NSCLC), the well-developed epidermal growth factor receptor (EGFR) is an important therapeutic target. EGFR activating gene mutations have been proved strongly predictive of response to EGFR-tyrosine kinase inhibitors (TKI) in NSCLC. However, both in daily...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zheng, Yulong, Fang, Weijia, Deng, Jing, Zhao, Peng, Xu, Nong, Zhou, Jianying
Formato: Artigo
Idioma:Inglês
Publicado em: Pioneer Bioscience Publishing Company 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120162/
https://ncbi.nlm.nih.gov/pubmed/25093093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2014.07.18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados